Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
G.D. Searle LLC et al v. Lupin Pharmaceuticals, Inc. et al
Case Number:
2:13-cv-00121
Court:
Nature of Suit:
Judge:
Firms
- Cozen O'Connor
- Goodwin Procter
- Hunton Andrews
- Kaufman & Canoles
- Kelley Drye
- McGuireWoods
- Merchant & Gould
- Taft Stettinius
- Wilson Sonsini
- Woods Rogers
Companies
Sectors & Industries:
-
March 12, 2014
Judge Invalidates Reissue Patent For Pfizer's Celebrex
A Virginia federal judge on Wednesday invalidated a key Pfizer Inc. reissue patent covering methods for administering its blockbuster arthritis drug Celebrex, a ruling exposing the company to competition from generics makers.
-
March 05, 2013
Pfizer Targets Generic Celebrex After Extending Patent
Pfizer Inc. on Tuesday received an 18-month extension for its patent for the arthritis medication Celebrex, and promptly sued five drug companies for patent infringement for attempting to produce generic versions of the drug, the pharmaceutical giant said.